ERDHEIM-CHESTER DISEASE
Clinical trials for ERDHEIM-CHESTER DISEASE explained in plain language.
Never miss a new study
Get alerted when new ERDHEIM-CHESTER DISEASE trials appear
Sign up with your email to follow new studies for ERDHEIM-CHESTER DISEASE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Could existing cancer drugs tackle rare tumors? new trial aims to find out
Disease control Not yet recruitingThis trial tests whether two approved drugs, dabrafenib and trametinib, can treat rare cancers that have a specific genetic change called BRAF V600. These drugs are already used for melanoma and lung cancer, but researchers want to see if they help people with other cancer types.…
Matched conditions: ERDHEIM-CHESTER DISEASE
Phase: PHASE2, PHASE3 • Sponsor: Cancer Research UK • Aim: Disease control
Last updated Jun 27, 2026 09:09 UTC
-
500 patients to help unlock secrets of rare histiocytosis disorders
Knowledge-focused Not yet recruitingThis study will collect blood, saliva, urine, and stool samples from 500 adults with systemic histiocytosis—a group of rare inflammatory disorders. Researchers aim to identify biomarkers that could improve diagnosis, predict disease progression, and enable less invasive monitorin…
Matched conditions: ERDHEIM-CHESTER DISEASE
Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Knowledge-focused
Last updated Jun 26, 2026 14:07 UTC